Interpace Biosciences Inc (IDXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | |
| Sales | 416,875 | 174,902 | 101,080 | 54,670 |
| Cost of Goods | 304,352 | 130,121 | 77,990 | 44,390 |
| Gross Profit | 112,523 | 44,781 | 23,080 | 10,280 |
| Operating Expenses | 71,999 | 30,426 | 14,940 | 3,140 |
| Operating Income | 40,876 | 14,476 | 9,140 | 7,530 |
| Other Income | 4,864 | 3,471 | 2,040 | -11,680 |
| Pre-tax Income | 45,740 | 17,947 | 11,180 | -4,150 |
| Income Tax | 18,712 | 7,539 | 1,690 | 0 |
| Net Income Continuous | 27,028 | 10,408 | 6,710 | 2,592 |
| Net Income | $27,028 | $10,408 | $9,490 | $-4,150 |
| EPS Basic Total Ops | 200.00 | 87.00 | 71.00 | -56.00 |
| EPS Basic Continuous Ops | 200.16 | 87.04 | 71.16 | 34.70 |
| EPS Diluted Total Ops | 196.00 | 86.00 | 70.00 | -56.00 |
| EPS Diluted Continuous Ops | 196.24 | 85.54 | 70.19 | 34.70 |
| EBITDA(a) | $42,953 | $15,631 | $9,470 | $7,660 |